| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Protein |
| Molecule Category: | Salt |
| UNII: | FO8S2IW40N |
| Parent Compound: | LARAZOTIDE |
| InChI Key | NYGCNONRVCGHAT-UFIKZEAMSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C34H59N9O12 |
| Molecular Weight | 785.9 |
| AlogP | -3.18 |
| Hydrogen Bond Acceptor | 10.0 |
| Hydrogen Bond Donor | 9.0 |
| Number of Rotational Bond | 21.0 |
| Polar Surface Area | 301.32 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 51.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| PARTIAL AGONIST | Neuronal acetylcholine receptor; alpha3/beta4 partial agonist | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Celiac Disease | 2 | D002446 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2103815 |
| FDA SRS | FO8S2IW40N |
| PubChem | 44146842 |